BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

549 related articles for article (PubMed ID: 16998319)

  • 21. Transient myeloproliferative disorder and GATA1 mutation in neonates with and without Down syndrome.
    Tsai MH; Hou JW; Yang CP; Yang PH; Chu SM; Hsu JF; Chiang MC; Huang HR
    Indian J Pediatr; 2011 Jul; 78(7):826-32. PubMed ID: 21287369
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The key role of stem cell factor/KIT signaling in the proliferation of blast cells from Down syndrome-related leukemia.
    Toki T; Kanezaki R; Adachi S; Fujino H; Xu G; Sato T; Suzuki K; Tauchi H; Endo M; Ito E
    Leukemia; 2009 Jan; 23(1):95-103. PubMed ID: 18830255
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Expression of megakaryocytic and myeloid markers in blasts of transient abnormal myelopoiesis in a stillbirth with Down syndrome: report of histopathological findings of an autopsy case.
    Ishigaki H; Miyauchi J; Yokoe A; Nakayama M; Yanagi T; Taga T; Ohta S; Itoh Y; Ogasawara K
    Hum Pathol; 2011 Jan; 42(1):141-5. PubMed ID: 20970166
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Recent advances in the understanding of transient abnormal myelopoiesis in Down syndrome.
    Watanabe K
    Pediatr Int; 2019 Mar; 61(3):222-229. PubMed ID: 30593694
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Prenatal diagnosis of a transient myeloproliferative disorder in trisomy 21.
    Baschat AA; Wagner T; Malisius R; Gembruch U
    Prenat Diagn; 1998 Jul; 18(7):731-6. PubMed ID: 9706656
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Induction of hyperproliferative fetal megakaryopoiesis by an N-terminally truncated GATA1 mutant.
    Shimizu R; Kobayashi E; Engel JD; Yamamoto M
    Genes Cells; 2009 Sep; 14(9):1119-31. PubMed ID: 19682090
    [TBL] [Abstract][Full Text] [Related]  

  • 27. WT1 gene expression in children with Down syndrome and transient myeloproliferative disorder.
    Hasle H; Lund B; Nyvold CG; Hokland P; Østergaard M
    Leuk Res; 2006 May; 30(5):543-6. PubMed ID: 16242775
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A rare case of GATA1 negative chemoresistant acute megakaryocytic leukemia in an 8-month-old infant with trisomy 21.
    Stepensky P; Brooks R; Waldman E; Revel-Vilk S; Izraeli S; Resnick I; Weintraub M
    Pediatr Blood Cancer; 2010 Jul; 54(7):1048-9. PubMed ID: 20108342
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Analysis of GATA1 mutations in Down syndrome transient myeloproliferative disorder and myeloid leukemia.
    Alford KA; Reinhardt K; Garnett C; Norton A; Böhmer K; von Neuhoff C; Kolenova A; Marchi E; Klusmann JH; Roberts I; Hasle H; Reinhardt D; Vyas P;
    Blood; 2011 Aug; 118(8):2222-38. PubMed ID: 21715302
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Transient abnormal myelopoiesis of infancy associated with trisomy 21.
    Homans AC; Verissimo AM; Vlacha V
    Am J Pediatr Hematol Oncol; 1993 Nov; 15(4):392-9. PubMed ID: 8214361
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Blast cell deficiency of CD11a as a marker of acute megakaryoblastic leukemia and transient myeloproliferative disease in children with and without Down syndrome.
    Boztug H; Schumich A; Pötschger U; Mühlegger N; Kolenova A; Reinhardt K; Dworzak M
    Cytometry B Clin Cytom; 2013; 84(6):370-8. PubMed ID: 23450818
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Are GATA1 mutations occurring at random in Down syndrome transient leukemia?
    Satgé D
    Med Hypotheses; 2014 Aug; 83(2):154-9. PubMed ID: 24880866
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Improving circulatory disturbance in transient abnormal myelopoiesis.
    Koga H; Miyako K; Suga N; Hidaka T; Takahashi N
    J Pediatr Hematol Oncol; 2012 May; 34(4):e149-51. PubMed ID: 22134612
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Transient abnormal myelopoeisis in newborns with Down syndrome.
    Zarina AL; Hamidah A; Yong SC; Rohana J; Hamidah NH; Azma RZ; Boo NY; Jamal R
    Malays J Pathol; 2007 Dec; 29(2):107-11. PubMed ID: 19108403
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Down syndrome and leukemia, an update.
    Drabkin HA; Erickson P
    Prog Clin Biol Res; 1995; 393():169-76. PubMed ID: 8545449
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Functional differences between myeloid leukemia-initiating and transient leukemia cells in Down's syndrome.
    Chen J; Li Y; Doedens M; Wang P; Shago M; Dick JE; Hitzler JK
    Leukemia; 2010 May; 24(5):1012-7. PubMed ID: 20220775
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Transient myeloproliferative disorder in a neonate without Down syndrome].
    Adam M; Vincenot A; Gouraud F; Harvel C; Perot C; Portnoi MF; Andre-Kerneis E; Giraudier S; Leverger G; Favier R
    Ann Biol Clin (Paris); 2007; 65(5):569-73. PubMed ID: 17913678
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Transient abnormal myelopoiesis in non-Down syndrome neonate.
    Ohkawa T; Miyamoto S; Sugie M; Tomizawa D; Imai K; Nagasawa M; Morio T; Mizutani S; Takagi M
    Pediatr Int; 2015; 57(1):e14-7. PubMed ID: 25711269
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Transient myeloproliferative disorder with trisomy 12.
    Basu B; Gupta V
    Pediatr Hematol Oncol; 2010 Apr; 27(3):233-6. PubMed ID: 20367267
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Transient myeloproliferative disorder and acute myeloid leukemia in Down syndrome. An immunophenotypic analysis.
    Karandikar NJ; Aquino DB; McKenna RW; Kroft SH
    Am J Clin Pathol; 2001 Aug; 116(2):204-10. PubMed ID: 11488066
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 28.